Showing results (191-200 of 277) with videos related to

Sort By:
Pageof 28
Clinical Pharmacology and Therapeutics|October 30, 2021
The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 ActivityJean C Dinh, Erin C Boone, Vincent S Staggs, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 27, 2006
Variability of CYP2J2 expression in human fetal tissuesAndrea Gaedigk, Darren W Baker, Rheem A Totah, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2005
In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosaArtur V Cideciyan, Samuel G Jacobson, Tomas S Aleman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoniD Jankovic, L Aslund, I P Oswald, et al.
The European Respiratory Journal|April 12, 2000
Asthma morbidity 6 yrs after an effective asthma self-management programme in a Maori communityW J D'Souza, T Slater, C Fox, et al.
Clinical Pharmacology and Therapeutics|March 30, 2007
Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotypeA Gaedigk, J D Eklund, R E Pearce, et al.
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|June 22, 2011
Prevalence and incidence of hepatitis C virus infection among Aboriginal young people who use drugs: results from the Cedar ProjectKevin Jp Craib, Patricia M Spittal, Sheetal H Patel, et al.
Pageof 28